{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T20:42:18Z","timestamp":1794602538935,"version":"4.9.1"},"reference-count":176,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.ejmech.2024.116457","type":"journal-article","created":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T03:20:48Z","timestamp":1714533648000},"page":"116457","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Research progress of prodrugs for the treatment of cerebral ischemia"],"prefix":"10.1016","volume":"272","author":[{"given":"Hongwei","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dezhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongliang","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3373-011X","authenticated-orcid":false,"given":"Yong","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2024.116457_bib1","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.21037\/atm-20-4388","article-title":"Carotid artery stenosis and inflammatory biomarkers: the role of inflammation-induced immunological responses affecting the vascular systems","volume":"8","author":"Wijeratne","year":"2020","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.ejmech.2024.116457_bib2","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6745282","article-title":"Recognition of the possible miRNA-mRNA controlling network in stroke by bioinformatics examination","volume":"2021","author":"Li","year":"2021","journal-title":"Comput. Math. Methods Med."},{"key":"10.1016\/j.ejmech.2024.116457_bib3","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1001\/jamaneurol.2021.4346","article-title":"Twenty-year change in severity and outcome of ischemic and hemorrhagic strokes","volume":"79","author":"Toyoda","year":"2022","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.ejmech.2024.116457_bib4","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1002\/pmic.200300809","article-title":"ApoC-I and ApoC-III as potential plasmatic markers to distinguish between ischemic and hemorrhagic stroke","volume":"4","author":"Allard","year":"2004","journal-title":"Proteomics"},{"key":"10.1016\/j.ejmech.2024.116457_bib5","doi-asserted-by":"crossref","DOI":"10.1007\/s12035-023-03728-7","article-title":"The role of necroptosis in cerebral ischemic stroke","author":"Wang","year":"2023","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ejmech.2024.116457_bib6","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.3390\/antiox11122377","article-title":"Nrf2 regulates oxidative stress and its role in cerebral ischemic stroke","volume":"11","author":"Wang","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.ejmech.2024.116457_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2023.105656","article-title":"Research progress on mechanisms of ischemic stroke: regulatory pathways involving Microglia","volume":"172","author":"Gao","year":"2024","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ejmech.2024.116457_bib8","article-title":"Endoplasmic reticulum stress and the unfolded protein response in cerebral ischemia\/reperfusion injury","volume":"16","author":"Wang","year":"2022","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.ejmech.2024.116457_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.22130","article-title":"Heat-shock protein A12A attenuates oxygen-glucose deprivation\/reoxygenation-induced human brain microvascular endothelial cell dysfunction via PGC-1alpha\/SIRT3 pathway","volume":"85","author":"Li","year":"2024","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.ejmech.2024.116457_bib10","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.neuroscience.2022.10.020","article-title":"Emerging treatment strategies for cerebral ischemia-reperfusion injury","volume":"507","author":"Li","year":"2022","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejmech.2024.116457_bib11","doi-asserted-by":"crossref","first-page":"373","DOI":"10.4103\/1673-5374.228711","article-title":"Cerebral ischemia and neuroregeneration","volume":"13","author":"Lee","year":"2018","journal-title":"Neural Regen Res."},{"key":"10.1016\/j.ejmech.2024.116457_bib12","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3389\/fphar.2019.00297","article-title":"Melatonin protects MCAO-induced neuronal loss via NR2A mediated prosurvival pathways","volume":"10","author":"Shah","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.116457_bib13","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0361-9230(00)00363-4","article-title":"Characterization of transient focal ischemia-induced increases in extracellular glutamate and aspartate in spontaneously hypertensive rats","volume":"53","author":"Dawson","year":"2000","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ejmech.2024.116457_bib14","doi-asserted-by":"crossref","first-page":"6194","DOI":"10.1038\/onc.2008.297","article-title":"Caspases in apoptosis and beyond","volume":"27","author":"Li","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2024.116457_bib15","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nchembio711","article-title":"Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury","volume":"1","author":"Degterev","year":"2005","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2024.116457_bib16","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nchembio.83","article-title":"Identification of RIP1 kinase as a specific cellular target of necrostatins","volume":"4","author":"Degterev","year":"2008","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2024.116457_bib17","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/nm911","article-title":"A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia","volume":"9","author":"Borsello","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2024.116457_bib18a","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000353125","article-title":"Ischemia-reperfusion injury in stroke","volume":"1","author":"Nour","year":"2013","journal-title":"Interv. Neurol."},{"issue":"2","key":"10.1016\/j.ejmech.2024.116457_bib18b","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.neuron.2010.07.002","article-title":"The science of stroke: mechanisms in search of treatments","volume":"67","author":"Moskowitz","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.ejmech.2024.116457_bib19","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.2174\/1381612811319150014","article-title":"Reactive oxygen and nitrogen species in the renal ischemia\/reperfusion injury","volume":"19","author":"Rodriguez","year":"2013","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ejmech.2024.116457_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108073","article-title":"Licochalcone B attenuates neuronal injury through anti-oxidant effect and enhancement of Nrf2 pathway in MCAO rat model of stroke","volume":"100","author":"Zhou","year":"2021","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.ejmech.2024.116457_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110201","article-title":"BRG1 alleviates microglial activation by promoting the KEAP1-NRF2\/HO-1 signaling pathway and minimizing oxidative damage in cerebral ischemia-reperfusion","volume":"119","author":"Guo","year":"2023","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.ejmech.2024.116457_bib22","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3389\/fneur.2013.00030","article-title":"Microglia activation as a biomarker for traumatic brain injury","volume":"4","author":"Hernandez-Ontiveros","year":"2013","journal-title":"Front. Neurol."},{"key":"10.1016\/j.ejmech.2024.116457_bib23","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nrn2591","article-title":"The bright side of the glial scar in CNS repair","volume":"10","author":"Rolls","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ejmech.2024.116457_bib24","doi-asserted-by":"crossref","first-page":"344","DOI":"10.7150\/ijms.8140","article-title":"Glial scar formation occurs in the human brain after ischemic stroke","volume":"11","author":"Huang","year":"2014","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.ejmech.2024.116457_bib25","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/nrn1956","article-title":"Glial inhibition of CNS axon regeneration","volume":"7","author":"Yiu","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ejmech.2024.116457_bib26","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/0896-6273(94)90042-6","article-title":"A novel role for myelin-associated glycoprotein as an inhibitor of axonal regeneration","volume":"13","author":"Mukhopadhyay","year":"1994","journal-title":"Neuron"},{"key":"10.1016\/j.ejmech.2024.116457_bib27","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s43094-021-00289-1","article-title":"Cerebral ischemic stroke and different approaches for treatment of stroke","volume":"7","author":"Girnar","year":"2021","journal-title":"Future J. Pharmaceu. Sci."},{"key":"10.1016\/j.ejmech.2024.116457_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154664","article-title":"Pushen capsule treatment promotes functional recovery after ischemic stroke","volume":"111","author":"Zhang","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejmech.2024.116457_bib29","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jconrel.2021.10.020","article-title":"Nanomedicines, an emerging therapeutic regimen for treatment of ischemic cerebral stroke: a review","volume":"340","author":"Chen","year":"2021","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.ejmech.2024.116457_bib30","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1007\/s11064-022-03697-8","article-title":"Cell death mechanisms in cerebral ischemia-reperfusion injury","volume":"47","author":"Zhang","year":"2022","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ejmech.2024.116457_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106482","article-title":"Spatiotemporal lipidomics reveals key features of brain lipid dynamic changes after cerebral ischemia and reperfusion therapy","volume":"185","author":"Ma","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2024.116457_bib32","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.freeradbiomed.2020.05.015","article-title":"Therapeutic treatment with vitamin C reduces focal cerebral ischemia-induced brain infarction in rats by attenuating disruptions of blood brain barrier and cerebral neuronal apoptosis","volume":"155","author":"Chang","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejmech.2024.116457_bib33","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.2174\/0929867327666200812221022","article-title":"Drug repurposing: promises of edaravone target drug in traumatic brain injury","volume":"28","author":"Shakkour","year":"2021","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116457_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1357953","article-title":"Dl-3-n-butylphthalide attenuates cerebral ischemia\/reperfusion injury in mice through AMPK-mediated mitochondrial fusion","volume":"15","author":"Zhu","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.116457_bib35","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4103\/1673-5374.343906","article-title":"Characterization of retinal ganglion cell damage at single axon bundle level in mice by visible-light optical coherence tomography fibergraphy","volume":"18","author":"Liu","year":"2023","journal-title":"Neural Regen Res."},{"key":"10.1016\/j.ejmech.2024.116457_bib36","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrd3418","article-title":"Fresh from the pipeline. Ticagrelor","volume":"10","author":"Huber","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2024.116457_bib37","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000530504","article-title":"Efficacy and safety of ticagrelor versus aspirin and clopidogrel for stroke prevention in patients with vascular disease: a systematic review and meta-analysis","volume":"86","author":"Ma","year":"2023","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.ejmech.2024.116457_bib38","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13561-015-0052-8","article-title":"Estimation of the cost-effectiveness of apixaban versus vitamin K antagonists in the management of atrial fibrillation in Argentina","volume":"5","author":"Giorgi","year":"2015","journal-title":"Health Econ. Rev."},{"key":"10.1016\/j.ejmech.2024.116457_bib39","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s11239-017-1590-1","article-title":"Laboratory measurement of apixaban using anti-factor Xa assays in acute ischemic stroke patients with non-valvular atrial fibrillation","volume":"45","author":"Shin","year":"2018","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.ejmech.2024.116457_bib40","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1016\/j.sjbs.2021.04.017","article-title":"Neuroprotective effect of aspirin combined with ginkgolide injection on cerebral ischemic stroke rats and its effect on ERK12 signal pathway","volume":"28","author":"Zhang","year":"2021","journal-title":"Saudi J. Biol. Sci."},{"key":"10.1016\/j.ejmech.2024.116457_bib41","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1136\/svn-2023-002310","article-title":"Rationale and design of tenecteplase reperfusion therapy in acute ischaemic cerebrovascular events III (TRACE III): a randomised, phase III, open-label, controlled trial","volume":"9","author":"Xiong","year":"2024","journal-title":"Stroke Vasc. Neurol."},{"key":"10.1016\/j.ejmech.2024.116457_bib42","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/fcp.12782","article-title":"Edaravone dexborneol protects cerebral ischemia reperfusion injury through activating Nrf2\/HO-1 signaling pathway in mice","volume":"36","author":"Xu","year":"2022","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.116457_bib43","article-title":"Neuroinflammation and anti-inflammatory therapy for ischemic stroke","volume":"9","author":"Cao","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.ejmech.2024.116457_bib44","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1007\/s40265-023-01922-4","article-title":"Sovateltide: first approval","volume":"83","author":"Keam","year":"2023","journal-title":"Drugs"},{"key":"10.1016\/j.ejmech.2024.116457_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114464","article-title":"Minocycline promotes functional recovery in ischemic stroke by modulating microglia polarization through STAT1\/STAT6 pathways","volume":"186","author":"Lu","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.116457_bib46","doi-asserted-by":"crossref","first-page":"7739","DOI":"10.3390\/ijms13067739","article-title":"Clinical neuroprotective drugs for treatment and prevention of stroke","volume":"13","author":"Kikuchi","year":"2012","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.ejmech.2024.116457_bib47","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1016\/j.nano.2017.08.002","article-title":"Triphenyl phosphonium coated nano-quercetin for oral delivery: neuroprotective effects in attenuating age related global moderate cerebral ischemia reperfusion injury in rats","volume":"13","author":"Ghosh","year":"2017","journal-title":"Nanomedicine-UK"},{"issue":"1\u20132","key":"10.1016\/j.ejmech.2024.116457_bib48","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ijpharm.2017.10.040","article-title":"Solid lipid nanoparticles as carriers for oral delivery of hydroxysafflor yellow A","volume":"535","author":"Zhao","year":"2018","journal-title":"Int. J. Pharm. (Amst.)"},{"key":"10.1016\/j.ejmech.2024.116457_bib49","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jconrel.2023.11.002","article-title":"Astrocytes and microglia-targeted Danshensu liposomes enhance the therapeutic effects on cerebral ischemia-reperfusion injury","volume":"364","author":"Bai","year":"2023","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.ejmech.2024.116457_bib50","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.2174\/1570159X21666230717144752","article-title":"Neuroprotective strategies for stroke by natural products: advances and perspectives","volume":"21","author":"Liu","year":"2023","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.ejmech.2024.116457_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119321","article-title":"Effects of non-drug treatment on liver cells apoptosis during hepatic ischemia-reperfusion injury","volume":"275","author":"Wang","year":"2021","journal-title":"Life Sci."},{"issue":"11","key":"10.1016\/j.ejmech.2024.116457_bib52","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1097\/TP.0000000000001318","article-title":"Targeting ischemia reperfusion in intestinal transplantation by COX-2 inhibition-A S.M.A.R.T approach?","volume":"100","author":"Pascher","year":"2016","journal-title":"Transplantation"},{"issue":"21","key":"10.1016\/j.ejmech.2024.116457_bib53","doi-asserted-by":"crossref","first-page":"12485","DOI":"10.1021\/acs.jmedchem.0c00887","article-title":"From seeds of Apium graveolens linn. To a cerebral ischemia medicine: the long journey of 3-n-Butylphthalide","volume":"63","author":"Marco-Contelles","year":"2020","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2024.116457_bib54","doi-asserted-by":"crossref","first-page":"964","DOI":"10.14336\/AD.2019.0608","article-title":"Dl-3-n-butylphthalide reduces neurovascular inflammation and ischemic brain injury in mice","volume":"10","author":"Yang","year":"2019","journal-title":"Aging Dis."},{"key":"10.1016\/j.ejmech.2024.116457_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2020.147046","article-title":"Dl-3-n-butylphthalide attenuates hypoxic-ischemic brain injury through inhibiting endoplasmic reticulum stress-induced cell apoptosis and alleviating blood-brain barrier disruption in newborn rats","volume":"1747","author":"Fang","year":"2020","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.ejmech.2024.116457_bib56","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/aps.2017.90","article-title":"Conversion and pharmacokinetics profiles of a novel pro-drug of 3-n-butylphthalide, potassium 2-(1-hydroxypentyl)-benzoate, in rats and dogs","volume":"39","author":"Li","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"issue":"7","key":"10.1016\/j.ejmech.2024.116457_bib57","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1021\/jm4001693","article-title":"Novel hybrids of optically active ring-opened 3-n-butylphthalide derivative and isosorbide as potential anti-ischemic stroke agents","volume":"56","author":"Wang","year":"2013","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.ejmech.2024.116457_bib58","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1111\/bph.13025","article-title":"Melatonin-sulforaphane hybrid ITH12674 induces neuroprotection in oxidative stress conditions by a 'drug-prodrug' mechanism of action","volume":"172","author":"Egea","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.116457_bib59","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ejps.2015.01.010","article-title":"Pro-GLP-1, a Pro-drug of GLP-1, is neuroprotective in cerebral ischemia","volume":"70","author":"Zhang","year":"2015","journal-title":"Eur. J. Pharmaceut. Sci."},{"issue":"3","key":"10.1016\/j.ejmech.2024.116457_bib60","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrd2468","article-title":"Prodrugs: design and clinical applications","volume":"7","author":"Rautio","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"issue":"11","key":"10.1016\/j.ejmech.2024.116457_bib61","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1021\/ed065p947","article-title":"The prodrug concept and new drug design and development","volume":"65","author":"Riley","year":"1988","journal-title":"J. Chem. Educ."},{"key":"10.1016\/j.ejmech.2024.116457_bib62","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.addr.2017.06.013","article-title":"Prodrugs in medicinal chemistry and enzyme prodrug therapies","volume":"118","author":"Walther","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"18","key":"10.1016\/j.ejmech.2024.116457_bib63","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202101454","article-title":"Nanoparticulation of prodrug into medicines for cancer therapy","volume":"8","author":"Zhang","year":"2021","journal-title":"Adv. Sci."},{"issue":"10","key":"10.1016\/j.ejmech.2024.116457_bib64","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.addr.2012.10.001","article-title":"Amino acids as promoieties in prodrug design and development","volume":"65","author":"Vig","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.ejmech.2024.116457_bib65","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3390\/molecules21010075","article-title":"Chemical structure-related drug-like criteria of global approved drugs","volume":"21","author":"Mao","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2024.116457_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfa.2021.126512","article-title":"A dual-prodrug nanoparticle based on chitosan oligosaccharide for enhanced tumor-targeted drug delivery","volume":"619","author":"Chen","year":"2021","journal-title":"Colloid. Surface."},{"issue":"4","key":"10.1016\/j.ejmech.2024.116457_bib67","doi-asserted-by":"crossref","DOI":"10.1002\/adtp.201800030","article-title":"Stimuli-responsive prodrug chemistries for drug delivery","volume":"1","author":"Taresco","year":"2018","journal-title":"Adv. Therapeutics"},{"issue":"45","key":"10.1016\/j.ejmech.2024.116457_bib68","doi-asserted-by":"crossref","first-page":"15080","DOI":"10.1021\/acs.analchem.1c03153","article-title":"Noncovalent theranostic prodrug for hypoxia-activated drug delivery and real-time tracking","volume":"93","author":"Zhao","year":"2021","journal-title":"Anal. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2024.116457_bib69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11481-017-9725-x","article-title":"Nanomedicines for the treatment of CNS diseases","volume":"12","author":"Reynolds","year":"2017","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"1","key":"10.1016\/j.ejmech.2024.116457_bib70","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/s12951-021-01002-3","article-title":"Combination of cell-penetrating peptides with nanomaterials for the potential therapeutics of central nervous system disorders: a review","volume":"19","author":"Zhang","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.ejmech.2024.116457_bib71","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jconrel.2023.01.072","article-title":"Modulation of blood-brain tumor barrier for delivery of magnetic hyperthermia to brain cancer","volume":"355","author":"Wu","year":"2023","journal-title":"J. Contr. Release"},{"issue":"13","key":"10.1016\/j.ejmech.2024.116457_bib72","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.2174\/1381612826666200316130128","article-title":"Brain drug delivery: overcoming the blood-brain barrier to treat tauopathies","volume":"26","author":"Hanes","year":"2020","journal-title":"Curr. Pharmaceut. Des."},{"issue":"9\u201310","key":"10.1016\/j.ejmech.2024.116457_bib73","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1166\/jnn.2006.441","article-title":"The blood-brain barrier and brain drug delivery","volume":"6","author":"Koziara","year":"2006","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/j.ejmech.2024.116457_bib74","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/978-1-61779-310-3_21","article-title":"Prodrug design for brain delivery of small- and medium-sized neuropeptides","volume":"789","author":"Prokai-Tatrai","year":"2011","journal-title":"Methods Mol. Biol."},{"issue":"5","key":"10.1016\/j.ejmech.2024.116457_bib75","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1021\/mp400170b","article-title":"Drug delivery across the blood-brain barrier","volume":"10","author":"Khawli","year":"2013","journal-title":"Mol. Pharmacol."},{"issue":"3","key":"10.1016\/j.ejmech.2024.116457_bib76","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1055\/s-1998-1637","article-title":"Pro-nucleotides - recent advances in the design of efficient tools for the delivery of biologically active nucleoside monophosphates","volume":"9","author":"Meier","year":"1998","journal-title":"Synlett"},{"issue":"11","key":"10.1016\/j.ejmech.2024.116457_bib77","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1124\/dmd.123.001365","article-title":"Human carboxylesterase 1A plays a predominant role in hydrolysis of the anti-dyslipidemia agent fenofibrate in humans","volume":"51","author":"Li","year":"2023","journal-title":"Drug Metab. Dispos."},{"issue":"5","key":"10.1016\/j.ejmech.2024.116457_bib78","doi-asserted-by":"crossref","first-page":"392","DOI":"10.2165\/00003088-198510050-00002","article-title":"Clinical significance of esterases in man","volume":"10","author":"Williams","year":"1985","journal-title":"Clin. Pharmacokinet."},{"issue":"7","key":"10.1016\/j.ejmech.2024.116457_bib79","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/0006-2952(93)90459-A","article-title":"Human xenobiotic metabolizing esterases in liver and blood","volume":"46","author":"McCracken","year":"1993","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.ejmech.2024.116457_bib80","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0265689","article-title":"Physicochemical investigation of a novel curcumin diethyl gamma-aminobutyrate, a carbamate ester prodrug of curcumin with enhanced anti-neuroinflammatory activity","volume":"17","author":"Jithavech","year":"2022","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.ejmech.2024.116457_bib81","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1002\/cmdc.201100007","article-title":"Carbamate prodrug concept for hydroxamate HDAC inhibitors","volume":"6","author":"Schlimme","year":"2011","journal-title":"ChemMedChem"},{"issue":"2","key":"10.1016\/j.ejmech.2024.116457_bib82","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/path.4999","article-title":"Dissociation of nNOS from PSD-95 promotes functional recovery after cerebral ischaemia in mice through reducing excessive tonic GABA release from reactive astrocytes","volume":"244","author":"Lin","year":"2018","journal-title":"J. Pathol."},{"issue":"9","key":"10.1016\/j.ejmech.2024.116457_bib83","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/j.bmcl.2016.03.074","article-title":"Metabolic investigation on ZL006 for the discovery of a potent prodrug for the treatment of cerebral ischemia","volume":"26","author":"Chen","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.ejmech.2024.116457_bib84","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jpba.2004.09.054","article-title":"Simultaneous quantification of 12 bioactive components of Ligusticum chuanxiong Hort. by high-performance liquid chromatography","volume":"37","author":"Yan","year":"2005","journal-title":"J. Pharmaceut. Biomed."},{"issue":"1","key":"10.1016\/j.ejmech.2024.116457_bib85","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.taap.2012.09.016","article-title":"Ligustrazine attenuates oxidative stress-induced activation of hepatic stellate cells by interrupting platelet-derived growth factor-beta receptor-mediated ERK and p38 pathways","volume":"265","author":"Zhang","year":"2012","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"2","key":"10.1016\/j.ejmech.2024.116457_bib86","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s13318-011-0032-2","article-title":"Pharmacokinetic study of a novel stroke therapeutic, 2-[[(1,1-dimethylethyl)oxidoimino]methyl]-3,5,6-trimethylpyrazine, by a simple HPLC-UV method in rats","volume":"36","author":"Li","year":"2011","journal-title":"Eur. J. Drug Metab. Pharmokinet."},{"issue":"1\u20132","key":"10.1016\/j.ejmech.2024.116457_bib87","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jchromb.2004.09.048","article-title":"Liquid chromatography-mass spectrometry method for determination of tetramethylpyrazine and its metabolite in dog plasma","volume":"813","author":"Wang","year":"2004","journal-title":"J. Chromatogr. B"},{"issue":"4","key":"10.1016\/j.ejmech.2024.116457_bib88","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3109\/1061186X.2012.751536","article-title":"Development of 2-hydroxymethyl-3,5,6-trimethylpyrazine palmitate-loaded lipid emulsion: formulation, optimization, characterization, pharmacokinetics, biodistribution and pharmacodynamics","volume":"21","author":"Cao","year":"2013","journal-title":"J. Drug Target."},{"issue":"suppl_1","key":"10.1016\/j.ejmech.2024.116457_bib89","doi-asserted-by":"crossref","DOI":"10.1161\/str.48.suppl_1.tp169","article-title":"Abstract TP169: neuroprotective effect of pre-stroke statin therapy","volume":"48","author":"Zurr\u00fa","year":"2017","journal-title":"Stroke"},{"issue":"1\u20132","key":"10.1016\/j.ejmech.2024.116457_bib90","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jns.2004.01.015","article-title":"Effect of pretreatment with statins on the severity of acute ischemic cerebrovascular events","volume":"221","author":"Greisenegger","year":"2004","journal-title":"J. Neurol. Sci."},{"issue":"8","key":"10.1016\/j.ejmech.2024.116457_bib91","doi-asserted-by":"crossref","first-page":"589","DOI":"10.2165\/00023210-200115080-00002","article-title":"Do statins afford neuroprotection in patients with cerebral ischaemia and stroke?","volume":"15","author":"Vaughan","year":"2001","journal-title":"CNS Drugs"},{"issue":"4","key":"10.1016\/j.ejmech.2024.116457_bib92","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1747-4949.2006.00061.x","article-title":"Statins as acute-stroke treatment","volume":"1","author":"Elkind","year":"2006","journal-title":"Int. J. Stroke"},{"issue":"2","key":"10.1016\/j.ejmech.2024.116457_bib93","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.nbd.2005.12.004","article-title":"Activation of NF-kB and ERK1\/2 after permanent focal ischemia is abolished by simvastatin treatment","volume":"22","author":"Sironi","year":"2006","journal-title":"Neurobiol. Dis."},{"issue":"10","key":"10.1016\/j.ejmech.2024.116457_bib94","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0165-6147(02)02077-1","article-title":"Statins as anti-inflammatory agents","volume":"23","author":"Weitz-Schmidt","year":"2002","journal-title":"Trends Pharmacol. Sci."},{"issue":"3","key":"10.1016\/j.ejmech.2024.116457_bib95","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1747-4949.2008.00200.x","article-title":"The Neuroprotection with Statin Therapy for Acute Recovery Trial (NeuSTART): an adaptive design phase I dose-escalation study of high-dose lovastatin in acute ischemic stroke","volume":"3","author":"Elkind","year":"2008","journal-title":"Int. J. Stroke"},{"key":"10.1016\/j.ejmech.2024.116457_bib96","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.898955","article-title":"A review for the pharmacological effects of paeoniflorin in the nervous system","volume":"13","author":"Hong","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.116457_bib97","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.797298","article-title":"Pharmacological actions of myricetin in the nervous system: a comprehensive review of preclinical studies in animals and cell models","volume":"12","author":"Li","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.ejmech.2024.116457_bib98","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2478\/cipms-2019-0035","article-title":"An overview of techniques for multifold enhancement in solubility of poorly soluble drugs","volume":"32","author":"Ansari","year":"2019","journal-title":"Curr. Issues Pharm. Med. Sci."},{"key":"10.1016\/j.ejmech.2024.116457_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118498","article-title":"Is prodrug design an approach to increase water solubility?","volume":"568","author":"Sanches","year":"2019","journal-title":"Int. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.ejmech.2024.116457_bib100","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2174\/1381612805666230109214307","article-title":"Prodrug approaches to the improved delivery of peptide drugs","volume":"5","author":"Wang","year":"1999","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ejmech.2024.116457_bib101","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.addr.2007.05.013","article-title":"Prodrug strategies to overcome poor water solubility","volume":"59","author":"Stella","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"8","key":"10.1016\/j.ejmech.2024.116457_bib102","doi-asserted-by":"crossref","first-page":"870","DOI":"10.2174\/1389450122666201231130702","article-title":"Self-assembled micelles of amphiphilic PEGylated drugs for cancer treatment","volume":"22","author":"Al-Amili","year":"2021","journal-title":"Curr. Drug Targets"},{"issue":"2","key":"10.1016\/j.ejmech.2024.116457_bib103","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/72256","article-title":"Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke","volume":"6","author":"Manley","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2024.116457_bib104","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.neuroscience.2019.01.034","article-title":"Functionalized phenylbenzamides inhibit aquaporin-4 reducing cerebral edema and improving outcome in two models of CNS injury","volume":"404","author":"Farr","year":"2019","journal-title":"Neuroscience"},{"issue":"11","key":"10.1016\/j.ejmech.2024.116457_bib105","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1161\/STROKEAHA.122.038507","article-title":"Pharmacological characterization of a novel neuroactive steroid prodrug, NTS-104, and its neuroprotective activity in experimental stroke models","volume":"53","author":"Zhang","year":"2022","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.ejmech.2024.116457_bib106","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1055\/s-2007-969825","article-title":"Pharmacological properties of magnolol and honokiol extracted from Magnolia officinalis: central depressant effects","volume":"49","author":"Watanabe","year":"1983","journal-title":"Planta Med."},{"issue":"2","key":"10.1016\/j.ejmech.2024.116457_bib107","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1055\/s-2003-37707","article-title":"Honokiol ameliorates cerebral infarction from ischemia-reperfusion injury in rats","volume":"69","author":"Liou","year":"2003","journal-title":"Planta Med."},{"issue":"6","key":"10.1016\/j.ejmech.2024.116457_bib108","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.ajps.2018.11.004","article-title":"Synthesis, characterization and in vivo evaluation of honokiol bisphosphate prodrugs protects against rats' brain ischemia-reperfusion injury","volume":"14","author":"Xu","year":"2019","journal-title":"Asian J. Pharm. Sci."},{"issue":"5","key":"10.1016\/j.ejmech.2024.116457_bib109","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.jpba.2006.05.013","article-title":"HPLC determination of anethole trithione and its application to pharmacokinetics in rabbits","volume":"42","author":"Jing","year":"2006","journal-title":"J. Pharmaceut. Biomed."},{"issue":"1","key":"10.1016\/j.ejmech.2024.116457_bib110","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ijpharm.2009.06.001","article-title":"Lipid-based formulations to enhance oral bioavailability of the poorly water-soluble drug anethol trithione: effects of lipid composition and formulation","volume":"379","author":"Han","year":"2009","journal-title":"Int. J. Pharmacol."},{"issue":"9","key":"10.1016\/j.ejmech.2024.116457_bib111","doi-asserted-by":"crossref","first-page":"4595","DOI":"10.1021\/acsomega.9b04129","article-title":"Synthesis, characterization, and in vivo evaluation of desmethyl anethole trithione phosphate prodrug for ameliorating cerebral ischemia-reperfusion injury in rats","volume":"5","author":"Huang","year":"2020","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejmech.2024.116457_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104877","article-title":"Therapeutic targets of oxidative\/nitrosative stress and neuroinflammation in ischemic stroke: applications for natural product efficacy with omics and systemic biology","volume":"158","author":"Chen","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"7","key":"10.1016\/j.ejmech.2024.116457_bib113","doi-asserted-by":"crossref","first-page":"719","DOI":"10.4103\/1673-5374.131576","article-title":"3-N-butylphthalide improves neuronal morphology after chronic cerebral ischemia","volume":"9","author":"Zhao","year":"2014","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.ejmech.2024.116457_bib114","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/5012341","article-title":"A review of recent advances in neuroprotective potential of 3-N-butylphthalide and its derivatives","volume":"2016","author":"Abdoulaye","year":"2016","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.ejmech.2024.116457_bib115","series-title":"The Preparation and Application of 2-(\u03b1-Hydroxyamyl) Benzoate","author":"Yang","year":"2006"},{"key":"10.1016\/j.ejmech.2024.116457_bib116","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jconrel.2021.05.045","article-title":"Novel brain-targeting 3-n-butylphthalide prodrugs for ischemic stroke treatment","volume":"335","author":"Xiang","year":"2021","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.ejmech.2024.116457_bib117","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2022.106308","article-title":"Biopharmaceutical, preclinical pharmacokinetic and pharmaco-dynamic investigations of an orally administered novel 3-nbutylphthalide prodrug for ischemic stroke treatment","volume":"180","author":"Zhang","year":"2023","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejmech.2024.116457_bib118","series-title":"The Preparation and Application of 3-N-Butylphthalide Derivative","author":"Wang","year":"2016"},{"key":"10.1016\/j.ejmech.2024.116457_bib119","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.brainres.2010.08.043","article-title":"Protective effect of 3-butyl-6-bromo-1(3H)-isobenzofuranone on hydrogen peroxide-induced damage in PC12 cells","volume":"1358","author":"Gao","year":"2010","journal-title":"Brain Res."},{"issue":"5","key":"10.1016\/j.ejmech.2024.116457_bib120","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/j.ejmech.2010.01.036","article-title":"Synthesis and biological activity of n-butylphthalide derivatives","volume":"45","author":"Wang","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116457_bib121","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3389\/fphar.2016.00255","article-title":"Preclinical pharmacokinetics, tissue distribution, and plasma protein binding of sodium (+\/-)-5-Bromo-2-(alpha-Hydroxypentyl) benzoate (BZP), an innovative potent anti-ischemic stroke agent","volume":"7","author":"Tian","year":"2016","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.ejmech.2024.116457_bib122","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3390\/molecules21040501","article-title":"LC-MS\/MS analysis and pharmacokinetics of sodium (+\/-)-5-Bromo-2-(alpha-hydroxypentyl) benzoate (BZP), an innovative potent anti-ischemic stroke agent in rats","volume":"21","author":"Tian","year":"2016","journal-title":"Molecules"},{"issue":"9","key":"10.1016\/j.ejmech.2024.116457_bib123","doi-asserted-by":"crossref","first-page":"6048","DOI":"10.1111\/jcmm.14468","article-title":"Sodium (+\/-)-5-bromo-2-(alpha-hydroxypentyl) benzoate ameliorates pressure overload-induced cardiac hypertrophy and dysfunction through inhibiting autophagy","volume":"23","author":"Wang","year":"2019","journal-title":"J. Cell Mol. Med."},{"issue":"13","key":"10.1016\/j.ejmech.2024.116457_bib124","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1016\/j.bmcl.2005.05.002","article-title":"Water soluble prodrug of a COX-2 selective inhibitor suitable for intravenous administration in models of cerebral ischemia","volume":"15","author":"Smith","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"7","key":"10.1016\/j.ejmech.2024.116457_bib125","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.bmc.2019.02.046","article-title":"Synthesis and biological evaluation of paclitaxel and vorinostat co-prodrugs for overcoming drug resistance in cancer therapy in vitro","volume":"27","author":"Liu","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116457_bib126","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2023.112382","article-title":"Esterase-triggered rapid release of succinic anhydride conjugated curcumin co-prodrug for osteosarcoma therapy","volume":"198","author":"Wan","year":"2023","journal-title":"Eur. Polym. J."},{"issue":"31","key":"10.1016\/j.ejmech.2024.116457_bib127","doi-asserted-by":"crossref","first-page":"19844","DOI":"10.1021\/acsomega.0c02832","article-title":"Honokiol-chlorambucil Co-prodrugs selectively enhance the killing effect through STAT3 binding on lymphocytic leukemia cells in vitro and in vivo","volume":"5","author":"Xia","year":"2020","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejmech.2024.116457_bib128","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.niox.2022.09.002","article-title":"There is no direct competition between arginase and nitric oxide synthase for the common substrate l-arginine","volume":"129","author":"Momma","year":"2022","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.ejmech.2024.116457_bib129","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/1015908","article-title":"Intraplatelet L-arginine-nitric oxide metabolic pathway: from discovery to clinical implications in prevention and treatment of cardiovascular disorders","volume":"2020","author":"Gawrys","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.ejmech.2024.116457_bib130","doi-asserted-by":"crossref","first-page":"4767","DOI":"10.1038\/s41598-017-04965-2","article-title":"The prognostic biomarker L-homoarginine is a substrate of the cationic amino acid transporters CAT1, CAT2A and CAT2B","volume":"7","author":"Chafai","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2024.116457_bib131","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/SAP.0000000000002117","article-title":"Pharmaceutical preconditioning with nitric oxide synthase and L-arginine in ischemic tissues","volume":"84","author":"Gazyakan","year":"2020","journal-title":"Ann. Plast. Surg."},{"key":"10.1016\/j.ejmech.2024.116457_bib132","series-title":"Salt Formed by 2-(1-acyloxy Npentyl) Benzoic Acid and Basic Amino Acid or Aminoguanidine, Preparation Method and Use","author":"Zhang","year":"2019"},{"issue":"17","key":"10.1016\/j.ejmech.2024.116457_bib133","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.1016\/j.bmcl.2015.06.090","article-title":"Novel hybrids of 3-n-butylphthalide and edaravone: design, synthesis and evaluations as potential anti-ischemic stroke agents","volume":"25","author":"Sheng","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2024.116457_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2022.116891","article-title":"Synthesis and biological evaluation of hybrids from optically active ring-opened 3-N-butylphthalide derivatives and 4-fluro-edaravone as potential anti-acute ischemic stroke agents","volume":"69","author":"Jia","year":"2022","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116457_bib135","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119921","article-title":"Ferulic acid: a review of its pharmacology, pharmacokinetics and derivatives","volume":"284","author":"Li","year":"2021","journal-title":"Life Sci."},{"issue":"7","key":"10.1016\/j.ejmech.2024.116457_bib136","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.cclet.2020.02.031","article-title":"Design and synthesis of the ring-opened derivative of 3-n-butylphthalide-ferulic acid-glucose trihybrids as potential anti-ischemic agents","volume":"31","author":"Wu","year":"2020","journal-title":"Chin. Chem. Lett."},{"issue":"8","key":"10.1016\/j.ejmech.2024.116457_bib137","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.3390\/ijms23084243","article-title":"Roles of nitric oxide in brain ischemia and reperfusion","volume":"23","author":"Wang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.ejmech.2024.116457_bib138","doi-asserted-by":"crossref","first-page":"194","DOI":"10.4103\/2045-9912.215750","article-title":"The role of nitric oxide in stroke","volume":"7","author":"Chen","year":"2017","journal-title":"Med. Gas Res."},{"key":"10.1016\/j.ejmech.2024.116457_bib139","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1749-6632.1994.tb21823.x","article-title":"Role of nitric oxide in brain ischemia","volume":"738","author":"Sato","year":"1994","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"3\u20134","key":"10.1016\/j.ejmech.2024.116457_bib140","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ceca.2004.02.011","article-title":"Role of nitric oxide after brain ischaemia","volume":"36","author":"Moro","year":"2004","journal-title":"Cell Calcium"},{"issue":"9","key":"10.1016\/j.ejmech.2024.116457_bib141","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1161\/01.RES.87.9.825","article-title":"Mechanisms of NO\/cGMP-dependent vasorelaxation","volume":"87","author":"Sausbier","year":"2000","journal-title":"Circ. Res."},{"issue":"8","key":"10.1016\/j.ejmech.2024.116457_bib142","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/j.bbadis.2018.11.007","article-title":"Functions and dysfunctions of nitric oxide in brain","volume":"1865","author":"Picon-Pages","year":"2019","journal-title":"BBA-Mol. Basis Dis."},{"key":"10.1016\/j.ejmech.2024.116457_bib143","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/2979260","article-title":"Role of the platelets and nitric oxide biotransformation in ischemic stroke: a translative review from bench to bedside","volume":"2020","author":"Bladowski","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"12","key":"10.1016\/j.ejmech.2024.116457_bib144","article-title":"S-nitrosoglutathione mimics the beneficial activity of endothelial nitric oxide synthase-derived nitric oxide in a mouse model of stroke","volume":"28","author":"Khan","year":"2019","journal-title":"J. Stroke Cerebrovasc."},{"key":"10.1016\/j.ejmech.2024.116457_bib145","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106346","article-title":"Novel 2,6-disubstituted benzofuran-3-one analogues improve cerebral ischemia\/reperfusion injury via neuroprotective and antioxidative effects","volume":"132","author":"Yang","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2024.116457_bib146","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.yjmcc.2014.01.012","article-title":"Nitrite reduction and cardiovascular protection","volume":"73","author":"Omar","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"1","key":"10.1016\/j.ejmech.2024.116457_bib147","article-title":"Low dose nitrite improves reoxygenation following renal ischemia in rats","volume":"7","author":"Cantow","year":"2017","journal-title":"Sci. Rep-UK"},{"issue":"11","key":"10.1016\/j.ejmech.2024.116457_bib148","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1161\/01.STR.0000245116.40163.1c","article-title":"Early intravenous infusion of sodium nitrite protects brain against in vivo ischemia-reperfusion injury","volume":"37","author":"Jung","year":"2006","journal-title":"Stroke"},{"issue":"4","key":"10.1016\/j.ejmech.2024.116457_bib149","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1021\/jm701491k","article-title":"Synthesis and biological evaluation of NO-donor-tacrine hybrids as hepatoprotective anti-Alzheimer drug candidates","volume":"51","author":"Fang","year":"2008","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2024.116457_bib150","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1039\/B918846K","article-title":"Synthesis and anti-human hepatocellular carcinoma activity of new nitric oxide-releasing glycosyl derivatives of oleanolic acid","volume":"8","author":"Huang","year":"2010","journal-title":"Org. Biomol. Chem."},{"issue":"10","key":"10.1016\/j.ejmech.2024.116457_bib151","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.1016\/j.bmc.2010.03.077","article-title":"Synthesis and evaluation of nitric oxide-releasing derivatives of farnesylthiosalicylic acid as anti-tumor agents","volume":"18","author":"Ling","year":"2010","journal-title":"Bioorg. Med. Chem."},{"issue":"16","key":"10.1016\/j.ejmech.2024.116457_bib152","doi-asserted-by":"crossref","first-page":"5670","DOI":"10.1039\/c1ob05478c","article-title":"Design, synthesis and evaluation of nitric oxide releasing derivatives of 3-n-butylphthalide as antiplatelet and antithrombotic agents","volume":"9","author":"Wang","year":"2011","journal-title":"Org. Biomol. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2024.116457_bib153","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s12640-013-9444-x","article-title":"(S)-ZJM-289 preconditioning induces a late phase protection against nervous injury induced by transient cerebral ischemia and oxygen-glucose deprivation","volume":"26","author":"Zhang","year":"2014","journal-title":"Neurotox. Res."},{"issue":"12","key":"10.1016\/j.ejmech.2024.116457_bib154","first-page":"946","article-title":"Synthesis and biological evaluation of nitric oxide (NO)-hydrogen sulfide (H(2)S) releasing derivatives of (S)-3-n-butylphthalide as potential antiplatelet agents","volume":"14","author":"Wang","year":"2016","journal-title":"Chin. J. Nat. Med."},{"issue":"10","key":"10.1016\/j.ejmech.2024.116457_bib155","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1021\/acschemneuro.7b00126","article-title":"Quinolinyl Nitrone RP19 induces neuroprotection after transient brain ischemia","volume":"8","author":"Ayuso","year":"2017","journal-title":"CS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2024.116457_bib156","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.freeradbiomed.2017.12.027","article-title":"Development of a reactive oxygen species-sensitive nitric oxide synthase inhibitor for the treatment of ischemic stroke","volume":"115","author":"Nash","year":"2018","journal-title":"Free Radical Biol. Med."},{"issue":"8","key":"10.1016\/j.ejmech.2024.116457_bib157","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1080\/1061186X.2023.2247583","article-title":"The battle of lipid-based nanocarriers against blood-brain barrier: a critical review","volume":"31","author":"Abla","year":"2023","journal-title":"J. Drug Target."},{"issue":"45","key":"10.1016\/j.ejmech.2024.116457_bib158","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202270241","article-title":"Micro-Nanocarriers based drug delivery technology for blood-brain barrier crossing and brain tumor targeting therapy","volume":"18","author":"Wang","year":"2022","journal-title":"Small"},{"issue":"sup1","key":"10.1016\/j.ejmech.2024.116457_bib159","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/10717544.2017.1388451","article-title":"Cleavable PEGylation: a strategy for overcoming the \"PEG dilemma\" in efficient drug delivery","volume":"24","author":"Fang","year":"2017","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejmech.2024.116457_bib160","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jconrel.2016.04.010","article-title":"Readily adaptable release kinetics of prodrugs using protease-dependent reversible PEGylation","volume":"230","author":"Bottger","year":"2016","journal-title":"J. Contr. Release"},{"issue":"9\u201310","key":"10.1016\/j.ejmech.2024.116457_bib161","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1002\/jssc.201901340","article-title":"Recent advances in the bioanalytical methods of polyethylene glycols and PEGylated pharmaceuticals","volume":"43","author":"Zhang","year":"2020","journal-title":"J. Separ. Sci."},{"key":"10.1016\/j.ejmech.2024.116457_bib162","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.113923","article-title":"A network-based method for mechanistic investigation and neuroprotective effect on treatment of tanshinone I against ischemic stroke in mouse","volume":"272","author":"Liu","year":"2021","journal-title":"J. Ethnopharmacol."},{"issue":"5","key":"10.1016\/j.ejmech.2024.116457_bib163","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/ptr.2615","article-title":"Neuroprotective effects of Tanshinone IIA on permanent focal cerebral ischemia in mice","volume":"23","author":"Dong","year":"2009","journal-title":"Phytother Res."},{"issue":"14","key":"10.1016\/j.ejmech.2024.116457_bib164","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1055\/s-2006-951698","article-title":"Pharmacokinetics, absorption and tissue distribution of tanshinone IIA solid dispersion","volume":"72","author":"Hao","year":"2006","journal-title":"Planta Med."},{"issue":"1","key":"10.1016\/j.ejmech.2024.116457_bib165","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2019.126780","article-title":"PEG-amino acid-przewaquinone a conjugations: synthesis, physicochemical properties and protective effect in a rat model of brain ischemia-reperfusion","volume":"30","author":"Wang","year":"2020","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"3\u20134","key":"10.1016\/j.ejmech.2024.116457_bib166","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000500895","article-title":"Administration of a 20-hydroxyeicosatetraenoic acid synthesis inhibitor improves outcome in a rat model of pediatric traumatic brain injury","volume":"41","author":"Shu","year":"2019","journal-title":"Dev. Neurosci-Basel."},{"issue":"3","key":"10.1016\/j.ejmech.2024.116457_bib167","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/sj.bjp.0704101","article-title":"HET0016, a potent and selective inhibitor of 20-HETE synthesizing enzyme","volume":"133","author":"Miyata","year":"2001","journal-title":"Br. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.ejmech.2024.116457_bib168","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1038\/sj.jcbfm.9600309","article-title":"Protective effect of the 20-HETE inhibitor HET0016 on brain damage after temporary focal ischemia","volume":"26","author":"Poloyac","year":"2006","journal-title":"J. Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.ejmech.2024.116457_bib169","article-title":"Intravenous formulation of HET0016 decreased human glioblastoma growth and implicated survival benefit in rat xenograft models","volume":"7","author":"Jain","year":"2017","journal-title":"Sci. Rep-UK"},{"key":"10.1016\/j.ejmech.2024.116457_bib170","article-title":"Reactive oxygen species-responsive HET0016 prodrug-loaded liposomes attenuate neuroinflammation and improve neurological deficit in a rat model of juvenile traumatic brain injury","volume":"17","author":"Qin","year":"2023","journal-title":"Front. Neurosci-Switz."},{"issue":"5","key":"10.1016\/j.ejmech.2024.116457_bib171","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.ejmech.2010.01.006","article-title":"PEG-scutellarin prodrugs: synthesis, water solubility and protective effect on cerebral ischemia\/reperfusion injury","volume":"45","author":"Lu","year":"2010","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2024.116457_bib172","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/1098-1128(200009)20:5<367::AID-MED3>3.0.CO;2-P","article-title":"Targeting drugs to the brain by redox chemical delivery systems","volume":"20","author":"Prokai","year":"2000","journal-title":"Med. Res. Rev."},{"issue":"14","key":"10.1016\/j.ejmech.2024.116457_bib173","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S1359-6446(02)02332-2","article-title":"Barriers to remember: brain-targeting chemical delivery systems and Alzheimer's disease","volume":"7","author":"Bodor","year":"2002","journal-title":"Drug Discov. Today"},{"issue":"4","key":"10.1016\/j.ejmech.2024.116457_bib174","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s00044-018-2134-8","article-title":"Synthesis and biological evaluation of N-alkyl-1,4-dihydroquinoline prodrugs of scutellarin methyl ester as neuroprotective agents","volume":"27","author":"Dong","year":"2018","journal-title":"Med. Chem. Res."},{"issue":"3","key":"10.1016\/j.ejmech.2024.116457_bib175","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.apsb.2012.03.007","article-title":"Studies on tissue distribution of scutellarin and methyl polyethylene glycol (mPEG)-scutellarin prodrug in mice","volume":"2","author":"Lu","year":"2012","journal-title":"Acta Pharm. Sin. B"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424003374?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424003374?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,17]],"date-time":"2024-11-17T12:51:02Z","timestamp":1731847862000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523424003374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":176,"alternative-id":["S0223523424003374"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116457","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Research progress of prodrugs for the treatment of cerebral ischemia","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116457","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116457"}}